US$ 25.39
glp-1 agonist or antagonist Mechanisms of Receptor Agonist-Induced Weight Loss: A Review of Central and Peripheral Pathways in Appetite and Energy Regulation Nonconventional glucagon and GLP-1 receptor
Description
It said the review would consider safety data, including adverse drug reactions reported by patients and clinicians to the MHRA

B.WangB.GardnerE
Sources: AInvest, August 25, 2025

Exclusion Criteria Studies that did not explicitly study GLP-1-RAs or their therapeutic uses were excluded

The US GLP-1 receptor agonistmarket size was valued at USD 30.15 billion in 2025 and is projected to reach USD 33.84 billion in 2026